Article ID Journal Published Year Pages File Type
8315487 Clinica Chimica Acta 2012 5 Pages PDF
Abstract
► We assessed performances of AFP and AFP-L3 by the newly developed analyzer μTAS. ► Imprecision of AFP and AFP-L3 assays by the μTAS was all within 5% CV. ► AFP-L3 showed better diagnostic performance for hepatocellular carcinoma than AFP. ► The μTAS showed good performances for routine uses in measuring AFP and AFP-L3.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , ,